Bacteria engineered to treat diseases associated with hyperammonemia
US9487764B2 · kind B2 · utility
21Cited by
5References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2015 |
| Grant date | Nov 8, 2016 |
| Priority date | — |
| Expiry date | Dec 4, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.